SOMERVILLE, Mass.–(BUSINESS WIRE)–Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a seminal manuscript in the journal Science,…
Cellarity Publishes Framework for Discovery of Cell State-Correcting Medicines in Science
